These are the experts that write and produce content for Cannabis Health.
Cannabis Health has retained industry-leading experts in all aspects of the medical cannabis industry, including; physicians, universities, scientific researchers, innovative corporations and community advocates as contributors to the Journal.
Please check back for additional profiles in the coming weeks.
If you would like to contribute to Cannabis Health Journal, email our team at email@example.com.
Dr. Bearman has almost 40 year professional experience in the drug abuse treatment and prevention field includes being the Co-Director of the Haight-Ashbury Drug Treatment Program, being a member of Governor Reagan’s Inter Agency Task Force on Drug Abuse, a member of both the Santa Barbara and the San Diego County Drug Abuse Technical Advisor Committees, and a consultant to Hoffman-LaRoche, Santa Barbara County Schools and the National PTA. He has been recognized by the Santa Barbara Medical Society with the Humanitarian Recognition Award.
Since then, his pursuit of a wide range of modalities is a direct outcome of the understanding that, in order to accurately meet the needs of the individual, a practitioner must be able to draw from multiple and effective options.
Dr. Blaney specializes in bridging the more traditional scientific approach with the newer studies in naturopathic understanding. He spends the time needed to provide thorough care in order that he may help people not only recover from illness, but achieve greater longevity and quality of life. This interest is what initially led him into osteopathy.
In 1983 Dr. Blaney began his training in manual medicine at the College of Osteopathic Medicine, Michigan State University. His teachers (see below) are considered among the finest practitioners in history.
Dr. Blaney is a licensed general practitioner with over 30 years of experience in manual medicine, incorporating osteopathic manual therapy, craniosacral therapy and myofascial trigger point injections.
Dr. Grinspoon is a frequent lecturer on drug policy issues and has appeared as an expert witness before legislative committees in several states and several committees of the U.S. Congress. In 1990 he received the Alfred R. Lindesmith Award for Achievement in the Field of Scholarship and Writing from the Drug Policy Foundation in Washington, DC.
Dr. Grinspoon currently maintains www.marijuana-uses.com, which chronicles real life stories of people who have had positive “non-medical” experiences with marijuana.
Joost runs the GH Medical website, the Chemical Analysis Facility, the Biomedical Research Laboratory and the Clinical Trials. Dr. Heeroma’s mission is to collect everything there is to know about cannabinoids, explore their role in normal pathology, their prophylactic and therapeutic potential and make this available to patients and the general public.
As a general rule, life depends on a carefully maintained balance between order and chaos. The biological feedback mechanisms that maintain this ‘homeostatic’ balance from the central theme of his research. For his MSc thesis, Joost studied the genetic network that controls cell division and thereby protects the body from degeneration on the one hand and cancer on the other. For his PhD thesis, Joost studied how brain activity regulates itself via feedback control over brain structure (Heeroma et al., 2003, 2004; Verhage et al., 2000). As a postdoctoral researcher, Joost studied how the brain employs feed forward and feedback rules to encode memories and how mutations that disrupt negative feedback on brain activity cause diseases such as epilepsy (Heeroma et al., 2009; Lamsa et al., 2005, 2007). He later employed this principle to develop genetic therapy for epilepsy (Walker et al., 2013; Wykes et al., 2013).
Now Joost studies what is possibly the greatest group of feedback regulators of all: cannabinoids. Cannabinoids take center stage in some of the most critical cellular functions; the control of cell division, control of cellular energy supply and control of neuronal network activity. As such, cannabinoids are perfectly situated to develop therapies for diseases such as cancer, Alzheimer’s disease, epilepsy, depression, migraine, chronic pain, multiple sclerosis, arthritis, Crohn’s disease, anorexia, obesity and many more.
GH Medical has accumulated the world’s largest genetic library of cannabis strains including several unique landraces not previously described and potentially containing, yet undiscovered, cannabinoids. Joost aims to find these cannabinoids and test them, alone and in combination, for their physiological properties and to explore their full therapeutic potential. Details on Joost’s research references, include peer-reviewed journals can be found here.
Another key interest of his is understanding how individual variation in genes underlying the endocannabinoid system influence our responses to cannabis as a recreational drug and therapeutic substance.
Philippe is passionate about communication and enjoys synthesizing recent research findings and delivering this knowledge to a broad audience. He is a lecturer at the University of British Columbia, Okanagan campus and Adjunct Professor at the University of Northern British Columbia. Philippe also sits on the scientific advisory board for Canalogix Alternative Medicines and Pure Hemp Naturals, two Kelowna BC based companies and also contributes cannabis science pieces to Canlio.com, a Cannabis technology company based on British Columbia.
Following completion of his undergraduate degree, he was awarded the NSERC Alexander Graham Bell scholarship to perform graduate studies at the University of Guelph, Ontario. There, he studied crops genetically modified to increase nitrogen use efficiency and yield.
Upon the completion of his PhD in 2010, Dr. Hudson received the MITACS Elevate Industrial Fellowship to continue his study of nutrient utilization in transgenic rice and corn. He subsequently joined a commercial fertilizer company as their Molecular Biologist/Plant Physiologist in spring 2012 where he performed research and development on novel fertilizer products.
Dr. Hudson is now utilizing his expertise in molecular biology and plant physiology to optimize cultivation protocols and identify specific Cannabis varieties for their medicinal values.
In recent past, he dealt several business and research operations. His industrial experience spans from Advising, Innovating, Operating and Contributing towards developing multitude for R&D., including: Cellular & Molecular Genomics, Metabolomics, Therapeutics, Environment Mgmt., Alternative energy (Biofuels & Feed-stocks), Agri-Land Management, Food Safety and Sovereignty. Plant Breeding & Genetics, QC & QA of medicinal crops for drug platform development focusing on (NHP) Natural Health Products from highly potent Medicinal Plant Extracts.
He successfully led multi-disciplinary teams from (Professionals-Biologists, Engineers, Planners and Scientists) for several organizations, which resulted in consistent delivery of a broad range of products in a timely fashion. While working with a team of experts; he built a foundation of strong cross-functional skills including Research & Business development.
He holds his PhD., & MSc., in Cellular & Molecular Biology from a French Ivy League “INP-ENSAT” & had a Post-Doctorate from Michigan State University. Later, he served as a Faculty for Virginia-Tech, University of Wyoming & Texas-Tech University-Health Sci. Centre; respectively where he demonstrated an “Out-of-Box” approach for R&D. In 2010 his work was recognized by the US-DOE’s multi-million dollars grant for an alternative energy and globally by the United Nation’s-FAO (Food & Agriculture Organization). His scientific work has been published in over 22 peer-reviewed journals. He is multi-linguistic and has command over 12 languages including: English, French, Spanish, Hindi, Urdu, Guajarati, Sindhi, Punjabi, Kutchi, Khojki, Sariki and Arabic with excellent communication skills.
Dr. May has written many books and articles including a widely used textbook entitled Primary Care Medicine. Dr. May became an important formulator of nutritional products and served as executive vice president for medical and scientific affairs for Herbalife International. He has appeared in the media, lectured internationally, and consulted to industry and medical institutions, as well as serving on their boards. He was a founder of Physician’s Therapeutics and helped develop its parent company, Targeted Medical Pharma.
He is a Professor of Business, Science and Civics, representing Oaksterdam University across the nation as a subject matter expert to health care professionals, business leaders, politicians and the media while promoting education and improving public awareness.
Dr. Sappal holds a Medical Degree from India, serves on the Scientific Advisory Board of the Health Research Institute, which works with the Oregon Medical Marijuana Program, is on the board of the Public Education Program Fund and is an advisor for the Coalition for Cannabis Policy Reform (CCPR) and ReformCA.
He has lectured at numerous cannabis business conferences, often appears on media interviews as an expert, and writes for numerous magazines on the subjects of business, dispensary operations, horticulture and compliance. Dr Sappal is responsible for training numerous managers, business executives and investors on issues of compliance and best business practices. OU courses have gone on the road nationally under his leadership, with international courses on the horizon, as well as starting a research and development program for the university.
Dr. Sappal has overseen the production of campus videos and commercials, marketing, job placement, pharmacy programs, mandated education programs, training, certification and legislative advocacy.
In his current role, at Lexaria Energy, Chris has focused on the delivery of hemp oil compounds through gourmet foods based upon proprietary technologies. Specifically, actively developing and selling hemp oil-based gourmet food products through their subsidiary ViPova™ and under the Lexaria Energy brand. His dedication is steadfast to customers and shareholders and enjoys helping people understand the promise these technologies play in our everyday lives.
Known for his “tasteless” cannabutter and canna-oils as well as his gourmet and comfort food, Jeff’s extensive knowledge of cannabis and how to properly cook with the herb, coupled with his culinary skill, creativity, enthusiasm and passion in the kitchen has lent to his success in attracting a large fan base of medical cannabis patients who seek out his original recipes and cooking classes.
JeffThe420Chef recently made headlines when he introduced the world’s first THC/CBD Calculator to help other chefs and home cooks figure out the potency of their home made cannabis infused edibles.”
In 2014, Milestones Research was launched to address the present and historical roadblocks in conducting clinical research in the United States and around the world. As the Founder & CEO, he is committed to delivering the highest quality data, while maintaining unquestionable ethics, through scientifically informed research to positively impact lives. From this foundation, Milestones Research aims to be the leader as an independent and unbiased provider of clinical research dedicated to the investigation of cannabidiol (CBD) and other cannabis derivatives.
Max specializes in cannabis safety, education, and awareness. Working with lawyers, doctors, and scientists, Max educates everyone about the truths and complexities of cannabis culture and its industry. He is a founder of the Trichome Institute, an educational content provider for the modern cannabis industry.
The Trichome Institute provides standardized cannabis training for employees and produces educational tools for the cannabis consumer. These cannabis “connoisseur” products along with Trichome’s training guide users to understand the process of “Interpening.”
A renowned educator, Mr.Tomc recognizes CBD and its multiple mechanisms of action to support human health, and envisions a new category of dietary supplements derived from agricultural hemp.